Our Team

Seth has been practicing in the field of oncology since 1983 and just recently retired after 35 years in the Blood and Marrow Transplant (BMT) at the Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance.

Seth has published numerous peer-reviewed articles on chemotherapy and biotherapy, five book chapters including a chapter for the Joint Commission Resources on Closed System Transfer Devices (CSTDs), and serves as editor for a book on BMT. Seth is a nationally and internationally known speaker conducting many presentations at nursind and pharmacy conferences on a variety of topics and has been the principal investigator in two published nursing research studies.

Seth has been involved with the Oncology Nursing Society including serving as Coordinator for the Chemotherapy Special Interest Group, 5 years as contributing editor for ONS Connect, 5 years on the OCN test development committee and 5 years on the BMT Certification committee including 2 years as Committee Chair. He is currently a reviewe for the Clinical Journal of Oncology Nursing.

.

Thomas (Tom) Connor, PhD recently retired from the National Institute for Occupational Safety and Health (NIOSH) after almost 20 years working as a researcher on topics related to occupational exposure to hazardous drugs.

Before that, Tom was a faculty member at the University of Texas School of Public Health in Houston and conducted some of the early work on occupational exposure at the M.D. Anderson Cancer Center. Tom’s early work focused on evaluation of personal protective equipment for use with chemotherapy drugs and continued with ways to evaluate workplace contamination and exposure of workers to these drugs. He has published extensively and presented talks worldwide on this topic.

In 2004 he was the lead author on the NIOSH Alert Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings and has contributed to a number of professional and governmental guidance documents including USP Chapter 800 Hazardous Drugs-Handling in Healthcare Settings. In 2008 he received the American Society of Health-System Pharmacists Board of Directors’ award for contributions to the practice of pharmacy by a non-pharmacist.

Dr. Mitchell’s career has been focused on public health and occupational safety and health related to preventing infectious disease. She is the Executive Director of the Association of Occupational and Environmental Clinics (AOEC). AOEC is an organization of clinics and individuals committed to improving the practice of occupational and environmental medicine through information sharing and collaborative research. She also runs a successful consulting business and functions as a science advisor and subject matter expert for NIH/NIEHS, OSHA, and other Washington-based firms for infectious disease and the COVID-19 response. She serves as a board member for several occupational health and infection prevention organizations. Dr. Mitchell holds an adjunct faculty position at the University of Maryland School of Medicine Department of Occupational and Environmental Medicine with focus on occupational infection and hazardous drug prevention.

Dr. Mitchell began her career as the first OSHA National Bloodborne Pathogens Coordinator and has received several Secretary of Labor Excellence awards for her work on bioterrorism and public preparedness. She holds a Doctor of Public Health (DrPH) degree from the University of Texas School of Public Health and a Master’s in Public Health from The George Washington University. She is certified in Public Health as a member of the very first CPH cohort offered by the National Board of Public Health Examiners. Dr. Mitchell is also certified as a Fitness Nutrition Specialist with the American Council on Exercise and is training to be a Pilates Teacher.

She published her first book “Preventing Occupational Exposures to Infectious Disease in Health Care” for professionals with responsibility for infection prevention and control and occupational health and safety programs.

Barbara DeBaun has over 40 years of experience in the field of infection prevention and quality improvement. She is currently an independent consultant and an Improvement Advisor with Cynosure Health where she provides vision and leadership in the development, implementation and facilitation of infection prevention and quality improvement initiatives for healthcare organizations. Previously, she was an Improvement Advisor for BEACON, the Bay Area Patient Safety Collaborative, and was the Director of Patient Safety and Infection Control at California Pacific Medical Center in San Francisco. Barbara is a certified Infection Control Practitioner and holds a Bachelor’s degree in nursing from Pace University in New York and a Master of Science Degree in Nursing from San Francisco State University.

Barbara served two years as an elected member of APIC Board of Directors. Prior to her board service, she served as APIC’s liaison to the Centers for Disease Control’s Hospital Infection Control Practices Advisory Committee (HICPAC). Barbara has lectured nationally and internationally on a variety of patient safety and infection control topics and has published over a dozen articles and several book chapters.

Jeanne M. Regnante is a national leader in patient engagement, health equity, and cancer care transformation with more than 30 years of experience aligning research, healthcare delivery, and advocacy around the needs and interests of patients and communities. As a co-founder of Patient3i, she works across sectors to action strategic initiatives with Cancer Centers, Cancer Screening and Patient Safety focused startups, industry and national patient advocacy organizations focused on networking, authentic and culturally sensitive community engagement, equitable care, grant development, research questions, health literacy, and inclusive clinical research participation.

Previously, Jeanne served as Chief Health Equity and Diversity Officer at the LUNGevity Foundation, Head of Health Equity Strategy at Tigerlily Foundation and as a National Minority Quality Forum Program Officer, where she led the creation of patient-and community-inspired best practice data driven models and programs that advanced equity in cancer detection, health literacy, inclusive clinical trials, and survivorship outcomes with underserved populations. Prior to these roles, Jeanne worked at Merck & Co, where she worked cross-sector to modernize and establish global efforts in patient-centered drug development, inclusive clinical trials and health equity partnerships.

Jeanne recently worked with Industry leaders, NIH and Environmental Coalitions, which resulted in the passage of legislation to ban harvesting of horseshoe crabs in New York waters for human health safety and sustainably. She has authored numerous publications, blogs and book chapters and is routinely asked to speak at national meetings addressing strategies to reduce cancer disparities, representative clinical trials, strengthen community trust, and integrate and informed patient experience across the continuum of care for chronic diseases. Jeanne is an active and proud board member of Health Literacy Media, St Louis, MO.( 501c3). Currently, Jeanne is a judge for the Patient-Focused Medicine Development “Made With Patient” Awards , a recipient of the Cancer Health Top 25 Cancer Equity Leader Award, recognizing her national leadership in patient inclusion and health equity. Jeanne is actively working on and testing how AI enhances the acceleration of knowledge and efficiency of strategic implementation of patient and community engagement practices.